Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds
Phase 4
Recruiting
- Conditions
- Surgical Site InfectionSurgical WoundSurgical Wound Infection
- Interventions
- Drug: coated vicryl plusDrug: Vicryl
- Registration Number
- NCT04256824
- Lead Sponsor
- ClinAmygate
- Brief Summary
Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery
- Detailed Description
Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery. Also, comparing the post hospital stay.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 430
Inclusion Criteria
- age: 18-75
- clean-contaminated wound surgery
Exclusion Criteria
- Patient has immunodeficiency disorder.
- Patient receiving anti-cancer / immunosuppressive therapy.
- Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Coated Polyglactin 910 with Triclosan coated vicryl plus Coated vicryl plus Coated Polyglactin 910 without Triclosan Vicryl Coated vicryl
- Primary Outcome Measures
Name Time Method Incidence of surgical site infection 30 days Incidence of surgical site infection within 30 days
- Secondary Outcome Measures
Name Time Method Hospital stay 30 days duration of hospital stay
Trial Locations
- Locations (1)
Misr Univeristy for Science and Technology Hospital
🇪🇬Giza, Egypt